Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula

NARecruitingINTERVENTIONAL

Enrollment

139

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2026

Conditions

Functional Gastrointestinal Disorders

Interventions

DIETARY_SUPPLEMENT

New infant formula

The new formula will be given to infants during the 4-month study period.

Trial Locations (4)

NOT_YET_RECRUITING

Site 02, Nice

NOT_YET_RECRUITING

Site 04, Paris

RECRUITING

Site 03, Toulon

RECRUITING

Site 01, Vincennes

All Listed Sponsors

collaborator

Axiodis CRO

UNKNOWN

lead

United Pharmaceuticals

INDUSTRY

NCT06488274 - Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula | Biotech Hunter | Biotech Hunter